These principles echo earlier draft guidance on AI (Jan 2025) and general software guidance
The efficacy of tirzepatide (brand name Mounjaro) for weight management is well documented in clinical trials, and NICE recommended provision of the weekly injection in primary care in 2024
Side effect management is crucial for adherence and success
This temporary reaction occurs in approximately 5-10% of users and stems from the body's natural inflammatory response to the injection itself, not an allergy to the medication
Beyond obesity itself, these findings suggest future peptide therapies may address inflammation, cardiovascular risk, osteoarthritis, and broader metabolic dysfunction simultaneously
J Neural Transm 104:661677 Saharan S, Mandal PK (2014) The emerging role of glutathione in Alzheimer's disease